MetaCap

Starling Oncology Inc. Company Profile

NASDAQ: STLNHealth CareMedical/Nursing ServicesUSD

6.32-0.115 (-1.79%)

Market open · Delayed 15 min · as of Oct 8, 10:23 AM ET

Starling Oncology at a glance

Starling Oncology Inc. (NASDAQ: STLN) is a Medical/Nursing Services company in the Health Care sector headquartered in Cerritos, CA. Starling Oncology is led by Dr. Daniel Virnich FACHE, M.B.A., M.D. and employs about 641 people. The company's shares have traded publicly since 2020.

At a market capitalization of $655.3 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001799191, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Starling Oncology do?

Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The company was formerly known as The Oncology Institute, Inc. and changed its name to Starling Oncology, Inc. in August 2026. Starling Oncology, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Business description based on the company's public filings.

Company information

Legal name
Starling Oncology Inc.
Ticker
NASDAQ: STLN
Industry
Medical/Nursing Services
CEO
Dr. Daniel Virnich FACHE, M.B.A., M.D.
Employees
641
Headquarters
18000 Studebaker Road, Cerritos, CA, United States
Phone
562 735 3226
IPO year
2020
Market cap
$655.32M
SEC CIK
0001799191
Latest annual report
10-K · Mar 12, 2026

Companies similar to Starling Oncology

STLN peer companies
CompanyPrice% ChgMarket capCompare
SBCSBC Medical Group Holdings Incorporated5.18-3.00%$532.75Mvs STLN
AHCOAdaptHealth Corp.5.91+0.51%$788.45Mvs STLN
SRTAStrata Critical Medical Inc. Class A4.60-1.71%$406.95Mvs STLN
AUNAAuna SA Class A5.08+0.59%$376.21Mvs STLN
TDOCTeladoc Health Inc.5.50-1.17%$998.35Mvs STLN
PIIIP3 Health Partners Inc. Class A5.630.00%$1.15Bvs STLN
NAKANakamoto Inc.9.03-3.32%$161.59Mvs STLN
LFMDLifeMD Inc.2.69-3.76%$129.57Mvs STLN

Related